Charles River Laboratories International Inc
Charles River Laboratories Intern.../ US1598641074 /
CRL
|
2024-05-31 9:59:56 PM
|
Chg.
-1.36
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
208.40USD
|
-0.65%
|
44,136
Turnover: 9.22 mill. |
-Bid Size: - |
-Ask Size: - |
10.74 bill.USD |
- |
22.49 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
9.27 USD |
-3.13% |
| EPS Diluted: |
9.22 USD |
-2.74% |
| Revenues per Share: |
80.42 USD |
3.12% |
| Book Value per Share: |
70.15 USD |
19.98% |
| Cash Flow per Share: |
13.32 USD |
9.59% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
4,129.41 USD |
3.86% |
| Net Income: |
474.62 USD |
-2.39% |
| Operating Cash Flow: |
683.90 USD |
- |
| Cash and Cash Equivalents: |
276.77 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
22.49 |
25.50 |
| P/S Ratio: |
2.59 |
2.94 |
| P/BV ratio: |
2.97 |
3.37 |
| P/CF Ratio: |
15.65 |
17.75 |
| PEG: |
-7.17 |
-8.14 |
| Earnings Yield: |
4.45% |
3.92% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
10.74 bill. USD |
12.14 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
51.35 mill. |
|
Profitability
| Gross Profit Margin: |
36.39% |
| EBIT Margin: |
14.95% |
| Net Profit Margin: |
11.49% |
| Return on Equity: |
13.18% |
| Return on Assets: |
5.79% |
Financial Strength
| Liquidity I / Cash Ratio: |
26.23% |
| Liquidity II / Quick Ratio: |
100.20% |
| Liquidity III / Current Ratio: |
152.47% |
| Debt / Equity Ratio: |
127.50% |
| Dynam. Debt / Equity Ratio: |
671.55% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-30 |
| Accounting Standard: |
US GAAP |
